Michelle Robertson - Sep 6, 2022 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
EVP, CHIEF FINANCIAL OFFICER
Signature
/s/ Michelle Robertson
Stock symbol
EDIT
Transactions as of
Sep 6, 2022
Transactions value $
-$2,882
Form type
4
Date filed
9/8/2022, 04:30 PM
Previous filing
Jun 24, 2022
Next filing
Dec 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale -$2.88K -192 -0.23% $15.01 82.5K Sep 6, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2022. The sale does not represent a discretionary trade by the Reporting Person.